These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 8955657)

  • 21. Chemoradiation for adenocarcinoma of the anus.
    Papagikos M; Crane CH; Skibber J; Janjan NA; Feig B; Rodriguez-Bigas MA; Hung A; Wolff RA; Delclos M; Lin E; Cleary K
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):669-78. PubMed ID: 12573754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the cancer and Leukemia Group B (CALGB 9281).
    Meropol NJ; Niedzwiecki D; Shank B; Colacchio TA; Ellerton J; Valone F; Budinger S; Day JM; Hopkins J; Tepper J; Goldberg RM; Mayer RJ
    J Clin Oncol; 2008 Jul; 26(19):3229-34. PubMed ID: 18490648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epidermoid carcinomas of the anal canal treated with definitive radiation therapy in a series of 305 patients].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Houry S; Gallot D; Parc R; Huang R; Qu SH; Pène F; Schlienger M
    Cancer Radiother; 2003 Aug; 7(4):237-53. PubMed ID: 12914857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Definitive chemoradiotherapy for anal canal cancer: single-center experience.
    Tachibana I; Nishimura Y; Inada M; Fukuda K; Ishikawa K; Nishikawa T; Yokokawa M; Nakamatsu K; Kanamori S; Hida JI
    Int J Clin Oncol; 2018 Dec; 23(6):1121-1126. PubMed ID: 29992389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The prognostic factors following the simultaneous radiochemotherapy of anal canal carcinoma in a multicenter series of 139 patients].
    Grabenbauer GG; Panzer M; Hültenschmidt B; Döker R; Huber K; Kuhne-Velte HJ; Hutter M; Rühl U; Budach V; Wendt T
    Strahlenther Onkol; 1994 Jul; 170(7):391-9. PubMed ID: 8052938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy.
    Kachnic LA; Tsai HK; Coen JJ; Blaszkowsky LS; Hartshorn K; Kwak EL; Willins JD; Ryan DP; Hong TS
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):153-8. PubMed ID: 21095071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Squamous cell carcinoma of the anal canal.
    Mitchell SE; Mendenhall WM; Zlotecki RA; Carroll RR
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):1007-13. PubMed ID: 11240241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients.
    Cho BC; Ahn JB; Seong J; Roh JK; Kim JH; Chung HC; Sohn JH; Kim NK
    BMC Cancer; 2008 Jan; 8():8. PubMed ID: 18194582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase 1 study of cetuximab in combination with 5-fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma.
    Olivatto LO; Vieira FM; Pereira BV; Victorino AP; Bezerra M; Araujo CM; Erlich F; Faroni L; Castro L; Lusis EC; Marins A; Ferreira CG
    Cancer; 2013 Aug; 119(16):2973-80. PubMed ID: 23674135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Katori H; Tsukuda M; Taguchi T
    Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiation therapy in the conservative treatment of carcinoma of the anal canal.
    Wagner JP; Mahe MA; Romestaing P; Rocher FP; Berger C; Trillet-Lenoir V; Gerard JP
    Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):17-23. PubMed ID: 8175426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiotherapy for epidermoid carcinoma of the anus: thirty years' experience.
    Myerson RJ; Outlaw ED; Chang A; Birnbaum EH; Fleshman JW; Grigsby PW; Kodner IJ; Malayapa RS; Mutch MG; Parikh P; Picus J; Tan BR
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):428-35. PubMed ID: 19251377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research.
    Lancet; 1996 Oct; 348(9034):1049-54. PubMed ID: 8874455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Definitive combined modality therapy of carcinoma of the anus. A report of 30 cases including results of salvage therapy in patients with residual disease.
    Flam MS; John MJ; Mowry PA; Lovalvo LJ; Ramalho LD; Wade J
    Dis Colon Rectum; 1987 Jul; 30(7):495-502. PubMed ID: 3109860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concomitant chemoradiotherapy with Cisplatin plus 5-Fluorouracil for anal squamous cell carcinoma.
    El-Hadaad HA; Wahba HA; Roshdy S
    J Gastrointest Cancer; 2015 Jun; 46(2):156-60. PubMed ID: 25810165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pilot study of FMC (5-fluorouracil, mitomycin C, and cisplatin) with radiotherapy for patients with anal cancer.
    Lee IH; Lee SJ; Kang BW; Chae YS; Baek D; Hwang S; Kim HJ; Park SY; Park JS; Choi GS; Kim JC; Kim JG
    Cancer Chemother Pharmacol; 2016 Dec; 78(6):1263-1267. PubMed ID: 27830320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
    Ilson DH; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen DP
    J Clin Oncol; 1998 May; 16(5):1826-34. PubMed ID: 9586897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sphincter preservation with chemoradiation in anal canal carcinoma: abdominoperineal resection in selected cases?
    Grabenbauer GG; Matzel KE; Schneider IH; Meyer M; Wittekind C; Matsche B; Hohenberger W; Sauer R
    Dis Colon Rectum; 1998 Apr; 41(4):441-50. PubMed ID: 9559628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A clinical trial with protracted infusion 5-fluorouracil and mitomycin C for localized squamous cell carcinoma of the anus.
    Ngan D; Chu J; Chander S; Michael M; Heriot AG; Ngan SY; Rischin D; Leong T
    Asia Pac J Clin Oncol; 2019 Feb; 15(1):75-81. PubMed ID: 30536770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial.
    Ajani JA; Winter KA; Gunderson LL; Pedersen J; Benson AB; Thomas CR; Mayer RJ; Haddock MG; Rich TA; Willett C
    JAMA; 2008 Apr; 299(16):1914-21. PubMed ID: 18430910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.